BTTX (Better Therapeutics) Scaled Net Operating Assets: -0.19 (As of Sep. 2023)


What is Better Therapeutics Scaled Net Operating Assets?

Better Therapeutics BTTX Scaled Net Operating Assets is -0.19 as of Sep. 2023.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Better Therapeutics's operating assets for the quarter that ended in Sep. 2023 was $4.12 Mil. Better Therapeutics's operating liabilities for the quarter that ended in Sep. 2023 was $6.35 Mil. Better Therapeutics's Total Assets for the quarter that ended in Jun. 2023 was $11.60 Mil. Therefore, Better Therapeutics's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2023 was -0.19.

Better Therapeutics Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Better Therapeutics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Better Therapeutics Scaled Net Operating Assets Chart

Better Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Scaled Net Operating Assets
0.75 -1.28 0.89 -0.04

Better Therapeutics Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.06 -0.06 -0.22 -0.19

BTTX vs CYCN, CELZ, NRSN: Scaled Net Operating Assets Comparison

For the Biotechnology subindustry, Better Therapeutics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Better Therapeutics Scaled Net Operating Assets vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Better Therapeutics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Better Therapeutics's Scaled Net Operating Assets falls into.


Better Therapeutics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Better Therapeutics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2022 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2022 )
=(Operating Assets (A: Dec. 2022 )-Operating Liabilities (A: Dec. 2022 ))/Total Assets (A: Dec. 2021 )
=(7.203-8.962)/50.958
=-0.03

where

Operating Assets(A: Dec. 2022 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=22.943 - 15.74
=7.203

Operating Liabilities(A: Dec. 2022 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=23.842 - 10.348 - 4.532
=8.962

Better Therapeutics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2023 )
=(Operating Assets (Q: Sep. 2023 )-Operating Liabilities (Q: Sep. 2023 ))/Total Assets (Q: Jun. 2023 )
=(4.124-6.352)/11.604
=-0.19

where

Operating Assets(Q: Sep. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=10.722 - 6.598
=4.124

Operating Liabilities(Q: Sep. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=20.659 - 7.721 - 6.586
=6.352

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of -0.19 mean?
Better Therapeutics (BTTX) has a Scaled Net Operating Assets of -0.19 as of Sep. 2023. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Better Therapeutics and its competitors.
Is Better Therapeutics' Scaled Net Operating Assets too high?
Better Therapeutics' current Scaled Net Operating Assets is -0.19.
How does Better Therapeutics' Scaled Net Operating Assets compare to CYCN and CELZ?
Better Therapeutics' Scaled Net Operating Assets of -0.19 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Better Therapeutics and its competitors. Better Therapeutics's current Scaled Net Operating Assets is -0.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Better Therapeutics stock overvalued right now?
Better Therapeutics (BTTX) has a current Scaled Net Operating Assets of -0.19. The current Scaled Net Operating Assets is -0.19. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Better Therapeutics (BTTX), the current Scaled Net Operating Assets is -0.19 as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Better Therapeutics Business Description

Address 548 Market Street, Suite 49404, San Francisco, CA, USA, 94104
Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.